Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Starting soon

Conditions studied: Recurrent Prostate Cancer

In brief

Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.

Key facts

Study ID

NCT06070272

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-10-01

Expected to finish

2026-10-01

Last updated by the study team

2023-10-06

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patient is at least 18 years of age
• Diagnosis of recurrent prostate cancer
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if…

• Enrolled in another research study
• Patients with psychiatric illness/social situations that would limit compliance with study requirements
• Inability to provide written informed consent

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.